Table 2.
Clinical Characteristics of Patients With AF
| Patient No. | Age, y | Sex | Type | Ejection Fraction (%) | CHADS2 | Body Mass Index, kg/m2 | Bleeding | Recurrence | Cardioversion | Complication | Flow (LA/LAA) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 62 | F | Paro | 60 | 2 | 34.2 | 0 | AF | N/A | None | (−) |
| 2 | 58 | M | Paro | 61 | 2 | 38.7 | 0 | SR | N/A | None | (−) |
| 3 | 56 | M | Paro | 70 | 1 | 29.8 | 0 | SR | N/A | None | (−) |
| 4 | 60 | M | Paro | 61 | 1 | 22.8 | 1 | AF | N/A | None | (−) |
| 5 | 57 | M | Paro | 58 | 1 | 31.2 | 1 | SR | N/A | Pericarditis | (−) |
| 6 | 82 | F | Paro | 72 | 3 | 29.5 | 0 | AF | N/A | None | (+) |
| 7 | 66 | M | Paro | 66 | 4 | 28.7 | 0 | SR | N/A | None | (−) |
| 8 | 55 | M | Paro | 45 | 3 | 27.2 | 0 | AF | N/A | None | (−) |
| 9 | 71 | M | Paro | 62 | 4 | 32.4 | 1 | AF | N/A | None | (−) |
| 10 | 50 | M | Per | 65 | 1 | 33.3 | 0 | SR | Electrical | None | (−) |
| 11 | 65 | M | Per | 55 | 1 | 33.3 | 0 | SR | Electrical | None | (−) |
| 12 | 82 | M | Per | 63 | 1 | 23.7 | 1 | SR | Pharma | None | (−) |
| 13 | 65 | M | Per | 68 | 2 | 28.1 | 1 | SR | Electrical | None | (−) |
| 14 | 72 | M | Paro | 70 | 3 | 29.2 | 0 | AF | N/A | None | (−) |
| 15 | 59 | F | Paro | 69 | 2 | 28.5 | 0 | SR | N/A | None | (−) |
AF indicates atrial fibrillation; CHADS2, estimates risk based on the presence of congestive heart failure, hypertension, aged ≥75 y, diabetes mellitus, and prior stroke or transient ischemic attack; LA, left atrial; LAA, left atrial appendage; Paro, paroxysmal AF; N/A, not applicable; SR, sinus rhythm; Per, persistent AF; Pharma, pharmacological cardioversion.